In conclusion, our study confirms the presence of anti-PAD4 IgA in the serum samples of RA patients and the association of anti-PAD4 IgG with erosive RA, and is the first to report anti-PAD4 IgA as a highly specific marker for RA. Here, CD79A is linked to rheumatoid arthritis.